Clin2
NCT06605430Possibly a fitRecruiting

Medical cannabis for advanced pancreatic and colorectal cancer

Pancreatic Cancer Non-resectablePancreatic Cancer MetastaticColorectal Cancer Metastatic

Treatments studied

Part of Cancer clinical trials.

This trial tests whether medical cannabis can help reduce nausea, vomiting, appetite loss, wasting, and pain in people with advanced pancreatic or colorectal cancer who are starting chemotherapy. It's for Minnesota residents only.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
64 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 or older
  • You have advanced pancreatic or colorectal cancer that cannot be fully removed by surgery
  • You have had nausea, vomiting, poor appetite, weight loss, or pain in the past 2 weeks
  • You are starting or have started standard chemotherapy (not immunotherapy) within the past 2 weeks
  • You live in Minnesota and are willing to register with the Minnesota Medical Cannabis Program

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06030622Recruiting· Phase 1/Phase 2
Treatment for advanced pancreatic cancer after standard therapy

This trial tests a combination of three medicines to see if they can slow down or shrink pancreatic cancer that has not responded to previous treatments or has come back. It might help if you are generally healthy and your cancer is advanced.

Brooklyn, New York
NCT07342725Not yet recruiting· Phase 1/Phase 2
Combination treatment for advanced pancreatic cancer

This trial tests a new medicine (IBI363) combined with chemotherapy for people with advanced pancreatic cancer that has grown after their first treatment. The goal is to see if this combination can help shrink or control the cancer longer.

NCT06731894Recruiting· Phase 2
Cannabis for nerve pain after chemotherapy in breast and colon cancer survivors

This trial tests whether a cannabis-based product can reduce nerve damage (neuropathy) caused by chemotherapy in people who have finished treatment for breast or colon cancer. It focuses on survivors who still have pain, numbness, or tingling in their hands or feet.

Duarte, California
NCT07374939Not yet recruiting
Medical cannabis for chemotherapy nausea

This study looks at whether medical cannabis (marijuana) helps reduce nausea and vomiting caused by chemotherapy. If you join, you'll receive a cannabis product and track how well it works over several cycles.

Rochester, New York
NCT07459920Not yet recruiting· Phase 2
Cannabis extract for cancer-related symptoms

This trial tests whether a cannabis extract can help reduce symptoms like pain, nausea, anxiety, and poor appetite in people with advanced cancer. If you are already on strong pain medication and struggling with these symptoms, this study aims to see if adding cannabis improves your quality of life.

Naples
NCT06601218Recruiting· Phase 1
Daily oral cannabis for cancer patients with solid tumors

This trial tests whether taking a daily oral cannabis (marijuana) dose is safe for people with advanced solid tumors (cancer that has spread). It's looking for people who are already on a stable cancer treatment and want to see if adding cannabis affects their symptoms or how they feel.

Lexington, Kentucky

Hear when a new Pancreatic Cancer Non-resectable trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.